Xoma
Edit Page
Report
Scan day: 12 February 2014 UTC
15
Virus safety - good
Description: Development and manufacture of recombinant proteins and peptides, in partnership with big pharmas. Includes licensing of technology derived from the host-defense protein BPI, monoclonal antibodies to treat chemotherapy-induced thrombocytopenia, and to target cancer. Based in Berkeley, California.
XOMA Ltd. (Nasdaq: XOMA) is a biotechnology company focused on the discovery, development and manufacturing of monoclonal antibody-based therapeutics for serious unmet medical needs. XOMA's world-class monoclonal antibody technologies have contributed to the development of marketed biologics with a total of more than $1 billion in annual sales and for which XOMA received substantial royalties.
Size: 401 chars
Contact Information
Email: —
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
| Page title: | XOMA |
| Keywords: | |
| Description: | XOMA Ltd. (Nasdaq: XOMA) is a biotechnology company focused on the discovery, development and manufacturing of monoclonal antibody-based therapeutics for unmet medical needs. |
| IP-address: | 198.171.10.47 |
WHOIS Info
| NS | Name Server: NS.XOMA.COM Name Server: NS2.QUESTSYS.COM Name Server: NS3.QUESTSYS.COM |
| WHOIS | Status: clientTransferProhibited |
| Date | Creation Date: 16-jul-1995 Expiration Date: 15-jul-2015 |